about
Profound olfactory dysfunction in myasthenia gravisMyasthenia gravis and thymic neoplasms: A brief reviewCrystal structure of Fab198, an efficient protector of the acetylcholine receptor against myasthenogenic antibodiesMain Immunogenic Region Structure Promotes Binding of Conformation-Dependent Myasthenia Gravis Autoantibodies, Nicotinic Acetylcholine Receptor Conformation Maturation, and Agonist SensitivityExtracorporeal whole blood immunoadsorption of autoimmune myasthenia gravis by cellulose tryptophan adsorbentAntigenic structure of the human muscle nicotinic acetylcholine receptor main immunogenic regionStructural insights into the molecular mechanisms of myasthenia gravis and their therapeutic implications.Mechanisms of Autoantibody-Induced Pathology.Regulatory T cells in multiple sclerosis and myasthenia gravis.Specific immunotherapy of experimental myasthenia gravis by a novel mechanism.Autoantibodies to agrin in myasthenia gravis patients.In vivo adsorption of autoantibodies in myasthenia gravis using Nanodisc-incorporated acetylcholine receptor.The agrin/muscle-specific kinase pathway: new targets for autoimmune and genetic disorders at the neuromuscular junction.Antigen-specific immunotherapeutic vaccine for experimental autoimmune myasthenia gravisTargeting therapy to the neuromuscular junction: proof of concept.Protective effect of scFv-DAF fusion protein on the complement attack to acetylcholine receptor: a possible option for treatment of myasthenia gravis.Deficits in endogenous adenosine formation by ecto-5'-nucleotidase/CD73 impair neuromuscular transmission and immune competence in experimental autoimmune myasthenia gravis.Crosslinking-induced endocytosis of acetylcholine receptors by quantum dots.Effect of complement and its regulation on myasthenia gravis pathogenesis.Reactions of the immune system in epilepsyAnaesthetic considerations in paediatric myasthenia gravis.Direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patientsThe features of myasthenia gravis with autoantibodies to MuSK.Update on myasthenia gravis.Myasthenogenicity of the main immunogenic region and endogenous muscle nicotinic acetylcholine receptorsMolecular biology of channelopathies: impact on diagnosis and treatment.A targeted genome association study examining transient receptor potential ion channels, acetylcholine receptors, and adrenergic receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.Prospects for a T-cell receptor vaccination against myasthenia gravis.Maternal myasthenia gravis: a cause for arthrogryposis multiplex congenita.Receptor Crosslinking: A General Method to Trigger Internalization and Lysosomal Targeting of Therapeutic Receptor:Ligand Complexes.Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells.A comparison of epitope repertoires associated with myasthenia gravis in humans and nonhuman hosts.Myasthenogenicity of the main immunogenic region.Clinical significance of detection of antibodies to fetal and adult acetylcholine receptors in myasthenia gravisHypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis.In vivo injection of α-bungarotoxin to improve the efficiency of motor endplate labeling.Risk Factors and Outcomes in Cats with Acquired Myasthenia Gravis (2001-2012)Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity.Regulation of synaptic transmission and plasticity by neuronal nicotinic acetylcholine receptors.Paraneoplastic myasthenia gravis: immunological and clinical aspects.
P2860
Q21134037-27D488CF-C26F-4AD8-8283-12FA32D085ECQ26775077-87752288-439B-4753-A68F-4BA2429CC102Q27632866-86EB2BCA-165C-48DB-9824-A27783220C27Q27658065-EB2286A2-4698-49FF-B84A-8DDE8D54346EQ28258023-7FFDA29C-242A-4FAC-9FE1-714E159D9555Q33598797-60D2D845-3F35-4634-9293-EA5F511C6F0BQ33602986-85DC2F84-650B-4F42-80B8-AE437DDEEB14Q33740580-35B27912-21E6-4665-87B2-4E5901B0745CQ33784969-92152956-2B6F-49BD-AB9A-178F50EB39C8Q33831279-9EE0C3F6-9182-4C5D-98EF-AEA29FAF8373Q34040180-B8FDE9D1-EA67-4CE2-AC33-BD76B1DA155BQ34127035-0BBF358A-D1FC-4F9F-B648-406392C283D6Q34468998-6AD4F8FD-2D5C-4EC6-987C-D9E25194AEADQ34755933-084B96A9-E187-4BA3-8969-524E08D21AFEQ34974981-7A97CAE2-BA9A-4372-9AD6-B0BF266816F4Q35021471-86A587E7-4853-44BD-895D-DCFF9F3EC065Q35067400-B77ADCFA-C9A7-444F-8DD9-17609DBF2A20Q35108808-391D69A4-6F8E-41A1-989E-07273C0F2318Q35221722-66D94D6B-2FF3-4B12-9052-273F0E5B6B68Q35224998-7E4B033E-5B8E-4020-86FE-BC0958F7AFBFQ35231790-466F647A-40C6-4FBE-A8D9-E46221B21F6DQ35279680-16A24E8A-ACCC-4AE0-8FD8-9100D5190509Q35489482-34B5CA93-B82A-46D0-9136-5A4497EBA328Q35520740-7D24FA85-C299-45F2-9BB9-2F0894F3E69FQ35649128-34DEA70B-E0D4-497E-A399-63F3E4ABA38BQ36107015-A5273BA7-0ADB-4F84-BB66-6949158C4189Q36190203-E111A06C-5038-4712-A36E-DEB332F0167AQ36238694-7EBAE0A8-762E-4798-9331-4C9AD68B8516Q36322722-3ED77839-AB44-460B-82FC-B87D58D8F9ACQ36427101-BEBA4F30-BD0A-4081-BCF9-3AE7DA4AF2E9Q36440382-73283655-D0EC-4E5F-A892-BE631C5F4F4AQ36455616-B37CE2FF-86E9-4340-BFD7-5583974E8BAEQ36493237-7D16C04A-B06D-42C2-B499-48E06BE8EE1AQ36694363-3347EB2A-C175-49D3-85D1-F9F29E327255Q36700662-53F6B16D-71F4-4AF4-84BE-A79ACF53112CQ36853942-56AB31D5-E3CB-4704-A065-E4DE29434EB0Q36873499-1F2A98A7-48CB-4C77-AACC-3B4D83858A17Q36890894-3EC73C1B-1E5A-4A44-86F5-61B399884CC2Q36906265-15D34B3C-5A1D-4CA3-BE76-2A8E55542BD5Q37248720-7F969F92-50F9-4563-95AE-364561841DA4
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Acetylcholine receptors and myasthenia.
@ast
Acetylcholine receptors and myasthenia.
@en
type
label
Acetylcholine receptors and myasthenia.
@ast
Acetylcholine receptors and myasthenia.
@en
prefLabel
Acetylcholine receptors and myasthenia.
@ast
Acetylcholine receptors and myasthenia.
@en
P2860
P1433
P1476
Acetylcholine receptors and myasthenia.
@en
P2093
Lindstrom JM
P2860
P304
P356
10.1002/(SICI)1097-4598(200004)23:4<453::AID-MUS3>3.0.CO;2-O
P577
2000-04-01T00:00:00Z